Minimally Invasive Brain Science (02172): Artemis Dream® Chanjuan™ Self-Expanding Intracranial Rapamycin-Eluting Stent System Enters NMPA Innovation Green Channel

^{Zhitong Finance App News, Minimally Invasive Brain Science (02172) issued an announcement. The Artemis Dream® Chanjuan™ self-inflating intracranial rapamycin-eluting stent system (Artemis Dream®) developed by Minimally Invasive Shentong Medical Technology (Shanghai) Co., Ltd., a subsidiary of the Group, passed the National Drug Administration (NMPA) special review application for innovative medical devices and entered the special review process (green channel).} Up to now, the Group has included 7 products in the NMPA special review for innovative medical devices. The inclusion of this product marks another official recognition of the technical layout in the field of treatment of intracranial artery stenosis.

^{As an innovative product developed for clinical treatment pain points of intracranial artery stenosis, Artemis Dream® is the first self-inflating intracranial artery stent with targeted drug release in China. The core design advantages are as follows: Balanced support and long-term prognosis: Using a self-inflating stent structure design, mechanical support performance and metal coverage are accurately adjusted to reduce the possibility of vascular damage and re-stenosis at the structural level.} Achieve targeted drug release: Equipped with “single-sided groove” targeted drug delivery technology, the coating is firmer. The drug is only released in a targeted manner on the side of the blood vessel wall, which can inhibit endometrial hyperplasia, accelerate the endothelialization process, and help shorten the dual-antibody drug use cycle after surgery.

Artemis Dream ^® has now entered the “green channel” for innovative review, which will effectively shorten the product registration review cycle, promote early product launch to benefit patients, and further improve the Group's full-scene treatment product matrix for ischemic cerebrovascular disease.